An In Vivo Model for Postinflammatory Hyperpigmentation
NCT02905903
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Post-inflammatory Hyperpigmentation
Interventions
DRUG:
Tricholoacetic Acid (TCA)
Sponsor
Henry Ford Health System